InterVenn Biosciences announced the appointment of Jason Myers, Ph.D., and Carol Berry to the company’s Board of Directors.

CIRM Grant of $6.85 million supports the first-in-human clinical study evaluating the safety and efficacy of EBT-101 in participants people living with HIV

The integration maximizes the efficiency of downloading past building load data directly from the utility, which gives engineers a more accurate view of past usage and peak requirements of their project.

Experts in materials science, engineering, and operations will help Niron commercialize the world’s first high performance rare-earth free permanent magnets

Rosenberg will work with portfolio companies as they develop their intellectual property strategies and more broadly support the next generation of transformative technology companies.

This new partnership brings high-resolution, single-cell whole genome and whole transcriptome analysis to Europe. This partnership will enable novel insights and deep cellular characterization required in the evaluation, creation, and validation of new generation biologics and therapeutics in targeted disease management.

GelSight Mini enables an enhanced AI-enabled tactile experience for users in just five minutes out of the box.

ImmunoScape, a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR-T-cell therapeutics announced that it has raised $14M in new financing.

Xendee’s optimization software even takes into account cable length, losses through transferring energy, and the most efficient ways to generate and distribute energy from multiple energy sources at all hours of the day.

Excision BioTherapeutics announced that the first participant has been dosed in the Phase 1/2 clinical trial of EBT-101 for human immunodeficiency virus type 1 (HIV-1).

ImmunoScape announced that Dan MacLeod, Ph.D., the company’s vice president of discovery, will present at the 7th Annual CAR-TCR Summit taking place September 19-22, 2022 in Boston.

Growth investment accelerates product innovation, talent acquisition and expansion in commercial, educational markets

Excision BioTherapeutics Inc. announced that Excision Management will present at the following upcoming investor conferences.

6K Additive produced from its UniMelt® plasma technology, announces a strategic AM powder supply agreement and recycling partnership with Freeville, NY-based Incodema3D.

An open-access Battery Intelligence platform to analyze batteries, build models and algorithms, collaborate and share insights

Aldo Carrascoso, Co-Founder and CEO, and Erwin Estigarribia, COO, will present at the 20th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2022 in New York, NY

Seasoned CFO joins NTx with deep global experience in building financial systems for startups, venture capital, and investor relations

Successful issuance of over $5 million in convertible promissory notes to provide immediate capital to invest in the business

Grant to continue the development of imaging flow cytometry technology to sort cells based on features derived from artificial intelligence

The next-generation 3D printing solution will utilize area printing technology with the aim of building metal parts up to 100x faster

NUBURU, Inc. (“NUBURU”) has entered into a business combination agreement with Tailwind Acquisition Corp. (“TWND”)

Brancieri joins NTx to oversee cGMP certification for the manufacturing and distribution of platform raw materials

GreenSpur designed a new, rare earth-free 15MW generator based on Niron’s magnet technology that delivers a 56% reduction in mass and meets required efficiency targets

Jimmy’s promotion to Partner is a reflection of the years of hard work and passion he has put into his role as a key member of our investment team here at Anzu Partners

Ron Dizy brings over 25 years of energy industry leadership across strategy, finance, operations, engineering, and business development to e-Zinc’s board

The company’s new facilities add a large footprint of state-of-the-art laboratories and office space for scaling up InterVenn’s software development, technical support, clinical research and business development.

Nathan Duval, PhD, Lead Scientist, will present at the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) National Meeting

Following its Series A financing, BioFlyte welcomes national security and public safety executive Todd Sickles as CEO to accelerate productization and market penetration of its disruptive biodetection technology

Aspinity’s power-intelligent analogML solution named 2022 Best of Sensors Awards finalist

Fluent and NanoCellect are able to leverage and combine the unique advantages of our respective technologies to expand the use of single-cell RNA sequencing for rare cell populations.

A strong list of investors including TravelCenters of America Inc., Evergy Ventures, and Anzu Partners joined the oversubscribed $12M round

Several of NTx executives will attend the Biotechnology Innovation Organization (BIO) International Convention taking place at the San Diego Convention Center

With $32 Million in New Capital from Robert Bosch Venture Capital, Renesas, Anzu Partners and Arm, Arduino’s Vision for Universal Innovation Moves from the Garage and Classroom to the Enterprise With New Professional Offerings

Networks will be instrumental in reaching patients and caregivers, making them aware of our platform and realizing its potential

DAWN™ IO Melanoma is commercially available as a unique glycoproteomics laboratory-developed test (LDT) that aids Oncologists in planning treatment for Melanoma

BioSkryb launches an exclusive Early Access Program at AGBT 2022 for ResolveOME and BaseJumper, a bioinformatics platform to accelerate single-cell exploration

Paid demonstration will provide validation of commercial-scale e-Zinc long-duration energy storage system

6K Additive’s sustainably produced powders will be qualified for full industrialization and high-volume production.

Consumers Can Access the Diabetes Risk Test Kit As Well As Other Health and Wellness Tests Through Labcorp OnDemand

The investment is the first of two funding closes, expected to reach over $150M in total, aimed at building a low-cost, sustainable domestic supply chain for battery materials

GelSight will grow its presence in ten countries across Europe and Asia through four new distribution agreements

New financing will fuel international expansion and increase manufacturing capacity for its low power, sunlight-readable, and eye safe reflective LCD technology

Companies commence partnership to utilize NUBURU’s high power, high brightness blue laser technology and Essentium’s metal additive manufacturing platform to speed metal part production

Harvard University spinout advances a unique complementary metal-oxide-semiconductor (CMOS)-powered drug discovery platform that opens a new dimension in cell-based screening

Financing from LG Technology Ventures, Shell Ventures, TNSC, Anzu Partners, and Foothill Ventures will help increase market adoption of the company’s proven Liquefied Gas Electrolyte technology

The financing will accelerate field validation and production of the BioTOF™ z200, a bio-aerosol detection system

Award from the Center for Advanced Manufacturing at MassTech will Fund High-Tech Equipment to Recycle Scrap Materials Used in Additive Manufacturing and Battery Production

InterVenn to Showcase Novel Translational Research Opportunities Based on Glycoproteomics at AACR 2022

e-Zinc Secures USD $25 Million in Series A Financing to Advance Long-Duration Energy Storage